<DOC>
	<DOC>NCT00760786</DOC>
	<brief_summary>The purpose of this study is to determine whether intensive lipid lowering and Omega-3 fatty acid are effective in the treatment of coronary atherosclerotic plaque.</brief_summary>
	<brief_title>Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Plaque, Atherosclerotic</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Acute coronary syndrome within 48 hours of symptom onset Have de novo nonculprit coronary artery stenosis 20% to 70% by visual estimation Cardiogenic shock ST segment elevation myocardial infarction within 1 week Hematologic disorder: neutropenia (neutrophil&lt;3000/mm3), thrombocytopenia (platelet&lt;100,000/mm3) Liver enzyme elevation: serum aspartate aminotransferase or alanine aminotransferase concentrations more than 3 times the upper limit of normal Impaired renal function with serum creatinine &gt; 2mg/dL Bleeding diathesis or history of coagulopathy Pregnancy Hypersensitivity to heparin, dye, aspirin, clopidogrel, statin, or fish</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>IVUS-VH</keyword>
	<keyword>Plaque characterization</keyword>
	<keyword>Omega3-fatty acid</keyword>
	<keyword>Atorvastatin</keyword>
</DOC>